{"nct_id":"NCT04704219","title":"Pembrolizumab Plus Lenvatinib for First-line Advanced/Metastatic Non-clear Cell Renal Cell Carcinoma (1L nccRCC) (MK-3475-B61)","status":"ACTIVE_NOT_RECRUITING","status_verified_date":"2025-02","start_date":"2021-02-23","start_date_type":"ACTUAL","primary_completion_date":"2025-01-27","primary_completion_date_type":"ACTUAL","completion_date":"2025-10-25","completion_date_type":"ESTIMATED","phases":["PHASE2"],"tickers":["MRK"]}